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The idiopathic hypereosinophilic syndrome is defined as persistent eosinophilia of unknown origin. It is 
believed to be a reaction to an unidentified antigen or a inability of the organism to control its eosinophil production. 
The resultant eosinophilia is a systemic disorder that can be fatal, made manifest through the clinical signs of the affected 
organs. Eosinophilic invasion of tissues, associated with cytokine release and chemical mediators, determine organ 
damage and disfunction. Any organ can be affected, thus creating a puzzling clinical presentation. It commonly first 
affects the gastrointestinal tract, liver, spleen, bone marrow, lungs, and lymph nodes. Less frequently, it involves the 
skin, kidneys, heart, thyroid, adrenal glands and pancreas. It is believed that the Rottweiler is one of the breeds 
predisposed to this syndrome, alongside the German Shepherd, Siberian Husky, Alaskan Malamute and Cavalier King 
Charles Spaniel. We present the case of a Rottweiler with this rare disease and the steps taken to reach this uncommon 
diagnosis. 
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Introduction 
Eosinophils are polymorphonuclear leukocytes that can be distinguished morphologically 
once specific secondary granules develop at the progranulocyte stage are nowadays considered 
pleotrophic multifunctional cells that serve complex physiologic roles (Weiss DJ and Wardrop KJ, 
2010). Eosinophils develop in bone marrow and to a lesser extent in thymus, spleen, lung and 
lymph nodes, depending on the species, and their regulation depends on type 2 helper T (TH2) 
cells, which secrete IL-5 and IL-13. This includes increased production by bone marrow, mediated 
by IL-5 and recruitment to tissues by eotaxins, regulated by IL-13 (Weiss DJ and Wardrop KJ, 
2010). 
Eosinophils differentiate and mature in bone marrow over 2-6 days, depending on the 
species and comprise less than 10% of bone marrow nucleated cells (Weiss DJ and Wardrop KJ, 
2010). The half-life of eosinophils in circulation in healthy individuals is around 1 hour in the dog. 
Eosinophils migrate into tissues (in particular the gastrointestinal tract and lungs), where they last 
for about 2 days unless anti-apoptotic factors, such as IL-5, prolong their survival for up to 2 weeks 
cells (Weiss DJ and Wardrop KJ, 2010; Meler E et al, 2010). Under pathologic conditions, it is 
possible for eosinophils to re-enter circulation (Dale DC et al, 1976). Activated eosinophils change 
in morphology, cell surface characteristics and functional activities (Dvorak et al, 1997). These 
changes usually appear after eosinophils leave circulation, but they may be found in the blood of 
patients with allergic disease and hypereosinophilic syndrome (Weiss DJ and Wardrop KJ, 2010). 
Eosinophilia, defined as >1,500 eosinophils/μL of blood, is a frequent occurrence in dogs 
(Weiss DJ and Wardrop KJ, 2010). Eosinophilia occurs through inflammation and the elaboration 
of eosinophilopoietic factors (mainly IL-5) by T cells activated by parasite antigens or allergens 
(Herndon FJ and Kayes SG, 1992). 
Both endoparasites and ectoparasites cause eosinophilia (Weiss DJ and Wardrop KJ, 2010). 
Chronic eosinophilia is associated with inflammation of mast cell-rich organs – skin, lung, GI tract 
and uterus, in all species, as well as with eosinophilic myositis, eosinophilic panosteitis and 
eosinophilic gastroenteritis in dogs (Mansfield C, 2008; Weiss DJ and Wardrop KJ, 2010). 
Paraneoplastic eosinophilia is caused by a variety of tumors, such as lymphoma, mast cell tumor 
and solid tumors, in which IL-5 and other cytokines are elaborated (Fernández-Aceñero MJ et al, 




Rarely, eosinophilia is reported after administration of certain drugs in the dog and has 
been associated with tetracycline and recombinant IL-2 administration (Weiss DJ and Wardrop KJ, 
2010). Other causes of eosinophilia are presented in table 1. Chronic eosinophilic leukemia, a rare 
disease, must be differentiated from hypereosinophilic syndrome, where mild to moderate blood 
eosinophilia is accompanied by nonspecific tissue infiltration by eosinophils (Latimer et al, 2011) 
and the diagnosis depends on ruling out other causes and measuring serum IgE levels (Weiss DJ 
and Wardrop KJ, 2010). 
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Mast cell tumour 
Mucinous carcinomas 
Transitional cell carcinoma 
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Table 1. Causes of Eosinophilia 
 
Idiopathic hypereosinophilic syndrome (IHES) is described as a persistent eosinophilia of 
unknown origin and an increased survival of eosinophils in circulation, eosinophilic tissue 
infiltrates and consecutive organ dysfunction (Weiss DJ and Wardrop KJ, 2010). In humans, 
idiopathic hypereosinophilic syndrome is defined by sustained (over 6 months) peripheral 
eosinophilia of >1,500 cells/µL with no discernible cause and multiple organ involvement - 
gastrointestinal tract, liver, spleen, bone marrow, lungs, lymph nodes, skin, kidneys, heart, thyroid, 
adrenal glands and pancreas (Lilliehöök I et al., 2000; Weller PF and Bubley GJ, 1994; Sykes et al, 
2001). The difference between idiopathic hypereosinophilic syndrome and eosinophilic leukemia 
is difficult to establish and in some cases differentiation may not be possible (Sykes et al, 2001). 
One difference to be considered is that the maturation of eosinophils is regular in hypereosinophilic 
syndrome, while marked eosinophilic left shifts and bone marrow, blood and organ infiltrates are 
more likely in eosinophilic leukemia (Harvey JW, 2001). One mechanism suggested for 
eosinophilia is the clonal expansion of T cells generating eosinophilopoietic factors (Weller PF and 
Bubley GJ, 1994), and this increase in IL-5 levels can prevail over the apoptotic effects of 
corticosteroids; eosinophilia is sometimes observed in animals with hypoadrenocorticism due to 
decreased or absent cortisol (Weiss DJ and Wardrop KJ, 2010). 
Of all dog breeds, Rottweilers are the most predisposed to eosinophilic diseases, having 
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sex predisposition (Mansfield C, 2008). There seems to be a heritable component to eosinophilia 
(Mansfield C, 2008). Rottweilers are also the most frequently affected by hypereosinophilic 
syndrome. Sykes et al (2001) diagnosed 3 dogs with IHES on the basis of a lack of immature 
eosinophils and karyotype abnormalities (as opposed to eosinophilic leukemia), increased mean 
serum IgE concentration and the absence of an apparent cause. The absence of clonal karyotype 
abnormalities does not rule out underlying neoplasia; in human medicine, some patients with 
eosinophilic leukemia manifest cytogenetic abnormalities later on (Sykes et al, 2001; Rothenberg 
ME, 1998), therefore any patient diagnosed with IHES should be regularly monitored. 
The treatment of IHES in humans is based on glucocorticoids, which suppress cytokine 
gene transcription and inhibit cytokine-dependent eosinophil survival (Sykes et al, 2001). Patients 
resistant to glucocorticoids can be treated with hydroxyurea, vincristine, interferon or cyclosporine 
(Perkins MC, Watson AD, 2001; Lilliehöök I, Tvedten H, 2003). In veterinary medicine, the disease 
is more frequently described in cats than in dogs, but due to the small number of cases reported, 
the prognosis and best treatment options are not yet established (Ferian PE et al, 2017). Although 
it can be fatal in animals presenting with severe clinical symptoms, spontaneous remission is 
possible (Ferian PE et al, 2017; James FE and Mansfield CS, 2009). In human medicine, the main 
cause of death is eosinophilic cardiomyopathy due to infiltration and subsequent myocardial 
necrosis, mural thrombus formation and eventually subendocardial and endocardial fibrosis, 
culminating with congestive heart failure due to restrictive cardiomyopathy (Perkins MC, Watson 
AD, 2001).. 
 
Materials and methods 
Complete blood counts were performed at Synevovet Laboratory and in-house using a 
Mindray BC-2800 Vet automatic hematology analyzer. Blood biochemistry was performed in- 
house using a Rayto RT-1904C semiautomatic chemistry analyzer and at Synevovet. The 
cytological examinations were performed by Dr. Teodoru Soare. The cardiac examination was 
performed by dr. Florin Leca at Doctor's Vet Univers. The radiologic examinations were performed 
at 4VET Radiology Center and interpreted by dr. Florin Grosu. The ultrasonographic examinations 
were performed with a portable color Doppler Sonoscape S2 system by dr. Otilia Cristea. 
Case presentation 
Becko, a 4 year old fully intact Rottweiler, was presented to the vet for malaise and a loss 
of appetite. The clinical examination revealed fever (40ºC), tachycardia, tachypnea, generalised 
lymph node reactivity and a distended abdomen. Becko had always been correctly vaccinated and 
given internal and external parasite preventives. 
 




Figure 2. The evolution of Becko’s direct red blood cell parameters 









An in-house complete blood count (CBC) revealed intense neutropenia and eosinophilia, 
monocytopenia, lymphocytosis, mild non-regenerative anemia, decreased hematocrit and 
hemoglobin. The biochemisty revealed decreased albumin, increased total protein (TP) and mild 
hypocalcemia. Troponin I was 0.01 ng/mL (reference <0.08) showing no signs of myocardial 
injury. Blood cytology identified no signs of parasites/bacteria or hyperplastic/neoplastic cells. 
Ultrasonography of the abdomen revealed an enlarged but homogenous spleen and reactive 
abdominal lymph nodes. The dog was started on intravenous ceftriaxone and subcutaneous 
dexamethasone alongside supportive treatment. 
The next day, the dog’s state deteriorated and a procalcitonin titer of 2.5 ng/mL was 
obtained (reference value <0.5 ng/mL), supportive of a systemic infection and a high risk of sepsis. 
The dog presented with fever, lethargy, tachypnea and tachycardia. Becko responded to the 
treatment (his temperature dropped to 39ºC and he started to eat) after 4 days and the iv antibiotic 
was replaced with oral cephalexin. Dexamethasone was administered daily for 2 weeks beginning 
on the first day. Compensatory tachycardia and tachypnea continued despite the absence of fever 
due to the ensued anemia (figure 2). 
 
 
The cytologic examination of a popliteal lymph node aspirate revealed a heterogenous 
population of small, medium and large lymphocytes and plasmocytes and no evidence of neoplastic 
cells in the examined slides, consistent with a reactive lymph node. The superficial lymph nodes 
continued to be clinically enlarged and reactive for approximately 5-7 days. 
On day 8, after 4 days on oral antibiotics, the fever returned (41ºC). Becko was once again 
not eating and lethargic and his procalcitonin level was 2 ng/mL. He restarted iv ceftriaxone and 
was administered one dose of Theranekron, a homeopathic remedy prepared from the spider 
Tarantula cubensis, for its antiinflammatory properties. Blood biochemistry revealed low albumin, 
increased total protein, creatine kinase and alkaline phosphatase. The CBC revealed a mild 
regenerative anemia (RBC 4.9 M/μL, HGB 10.6 g/dL, HCT 31.6%) which gradually worsened 
over the next weeks (figure 2). Supportive treatment was continued throughout the period the dog 
was not eating on his own. 
As the fever continued, Becko was reffered for thoracic radiographs and a cadiac 
examination to exclude the possibility of bacterial endocarditis. The X-rays revealed a bronchial 
pattern indicative of a infectious or inflammatory disease and a physiological vertebral heart score. 
At the time of examination, the cardiologist identified a heart rate of 137 bpm, a capillary refill 
time of 2 seconds, normal mucous membrane color, no abnormalities of the peripheral pulse and 
normal breath sounds. With an increased PQ interval, Becko was diagnosed with a first degree 
atrioventricular block and scheduled for quarterly examinations. Ecocardiography did not reveal 




Two weeks after the initial episode, Becko was put on intravenous levofloxacin and 
meropenem, as his fever stopped responding to ceftriaxone. Despite being treated with 
dexamethasone, Becko had a marked eosinophilia and dexamethasone was replaced with 
prednisolone. The eosinophilia was suspicious, as Becko’s mother and 3 other male brothers had a 
history of an unexplicably increased eosinophil counts. We step by step investigated and ruled out 
the causes of eosinophilia (see table 1). The serum IgE level was determined twice with two week 
interval and was found to be normal, indicating that an allergic process is unlikely to be present. 
Toxoplasma gondii IgG and IgM (Synevovet) titers were <1:100 and considered negative. 
Repeated SNAP 4Dx Plus tests (IDEXX Laboratories, Inc.) were negative to all six vector-borne 
diseases. Coproparasitologic examinations were performed on three consecutive days and at 7, 10 
and 14 days using feces from each stool, from three different areas and from each fragment whose 
colour or texture were modified and they were all negative. Due to the continuous anemia, we 
tested a blood sample for the presence of Haemobartonella antigen but the test was negative. The 
dog had been eating the same food for over a year, there was no sign of gastroenteritis, any 
difficulty walking or any skin lesions. Eosinophilia was intermittently observed despite no 
evidence of allergic disease or other causes and treatment with corticosteroids (figure 3). Ultrasono- 
graphically, there was moderate hepato- and splenomegaly with a diffuse variation in echogenicity 
and slightly irregular margins. The abdominal lymph nodes were no longer visibly enlarged. 
 
Figure 3. Eosinophilia in response to glucocorticoids. The blood sample on day 1 
was obtained before treating with dexamethasone. 
 
The antibiotic was continued for 10 days and Becko showed signs of improvement on the 
second day of this regimen. His evolution was favourable and after a few days he was given oral 
methylprednisolone at 0.5 mg/kg, dose which was gradually increased to 2 mg/kg. 
Taking into account the history, paraclinical evidence and ultrasonographic changes, and 
considering Becko’s familial history, we suspected a case of idiopathic hypereosinophilic 
syndrome, overrepresented in Rottweilers. Due to the case’s evolution, the previous septic and 
inflammatory processes, the unexplicable fever and anemia and the continuous CBC variations, a 
bone marrow aspirate was submitted for a cytologic examination. The slide revealed a normal 
myeloid:erythroid ratio of 2:1 and the presence of all precursor cells for the erythroid, lymphoid 
and myeloid lineages. 
The confirmation came when the result indicated that over 28% of the myeloid cells were 
eosinophil precursors (in-house reference: <5%) and no signs of neoplasia in the examined cells. 
At the same time, concomitant blood cytology did not reveal eosinophilic precursors in the blood 
stream, which excluded, for now, the possibility of a eosinophilic leukemia. Becko’s mother and 




mother, which had been tested before each mating, recorded values which were never less than 5% 
eosinophils, manifesting a seasonal pattern with higher values in spring and autumn, when she 
would reach > 10% eosinophils. 
 
Figure 2. Photomicrograph of bone marrow fine needle aspiration, MGG, 1000x, showing 
pronounced eosinophilic hyperplasia, undifferentiated myeloid precursors with an eosinophilic 
differentiation and normal morphology. 
Source: prepared by Dr. T. Soare 
 
Unfortunately, Becko’s state gradually worsened, manifesting progressive generalised 
diffuse amyotrophy, including atrophy of the respiratory muscles and finally cachexia. The most 
significant change in blood biochemistry was hypoalbuminemia. Ultrasonography revealed large 
quantities of anechoic fluid in both body cavities and diffuse infiltrates of the abdominal organs, 
lungs and heart.The pleural and peritoneal fluids were examined cytologically and revealed a large 
number of eosinophils. Becko died of a cardiopulmonary arrest and the owner declined necropsy. 
 
Conclusions 
The first clinical sign Becko manifested was the fever of unidentified origin. 
The helpful diagnostic clues were the persistent recurrent eosinophilia despite 
glucocorticoid therapy and the familial history (the mother and brothers always registered over 5% 
eosinophils and occasionally over 10%, in particularly the male brothers). 
These, coupled with the unexplicable pyrexia, led to a suspicion of a genetic disease. Not 
every dog presenting with eosinophilia has idiopathic hypereosinophilic syndrome and it is 
essential to rule out the causes of increased eosinophil counts. 
If all investigations point to an idiopathic process, the dogs with persistent eosinophilia 
might benefit from early glucocorticoid therapy, before the onset of clinical disease, and should be 
subsequently subjected to regular clinical and paraclinical examinations. 
We observed that the dog responded better to prednisolone and methylprednisolone than 
to dexamethasone, as suggested in the literature. In severe cases, treatment seems to be illusive, 
therefore we recommend that eosinophilia in susceptible breeds, in particular the Rottweiler, be 
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